Phase II/III study of TTP273 for the treatment of type 2 diabetes.
Phase of Trial: Phase II/III
Latest Information Update: 19 Jun 2018
At a glance
- Drugs TTP 273 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 19 Jun 2018 New trial record
- 12 Jun 2018 audit According to the vTv Therapeutics LLC media release, company will is planning this trial in China and other Pacific Rim countries pursuant to a license agreement with Huadong Medicine.